Andrew J. Yee

6.2k citations

127 papers · 2.3k indexed · h-index 26

Hematology top 1%
- Multiple Myeloma Research and Treatments 89
Oncology top 2%
- CAR-T cell therapy research 18
- Peptidase Inhibition and Analysis 17
- Bone health and treatments 13
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 10
Molecular Biology top 5%
- Protein Degradation and Inhibitors 36
- Histone Deacetylase Inhibitors Research 11
- Amyloidosis: Diagnosis, Treatment, Outcomes 11
Pathology and Forensic Medicine top 5%

Co-authors: Noopur Raje Elizabeth O’Donnell Paul G. Richardson Cristina Panaroni Homare Eda Jill N. Burke Jacob P. Laubach Simon S. Jones
Cited by: Hematology Oncology Genetics
Journals: New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Circulation (1 paper)
Partner nations: United States Germany Australia

In The Last Decade

Andrew J. Yee

118 papers receiving 2.3k citations

Peers

Countries citing papers authored by Andrew J. Yee

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Yee more than expected).

Fields of papers citing papers by Andrew J. Yee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Yee. The network helps show where Andrew J. Yee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew J. Yee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew J. Yee Line = papers co-authored together Andrew J. Yee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combining Radiation Therapy with Bispecific Antibodies: Outcomes in Relapsed/Refractory Hematologic Malignancies International Journal of Radiation OncologyBiologyPhysics ·H.S. Ababneh,Andrew J. Yee,Noopur Raje,Matthew J. Frigault,P. Connor Johnson,C.G. Patel	2025	0
2	Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma Blood Advances ·Joshua Gustine,Andrew R. Branagan,Diana Cirstea,Farah Rexha,Ryan Han,Andrew J. Yee,Marcela V. Maus,Matthew J. Frigault,Noopur Raje	2025	1
3	Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury Blood Advances ·E. Bridget Kim,Jack Malespini,Matthew Lei,Samuel Han,Cole Minsky,Andrew R. Branagan,Elizabeth O’Donnell,Diana Cirstea,Noopur Raje,Andrew J. Yee	2025	2
4	Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy JACC. Cardiovascular imaging ·Dominik C. Benz,Olivier Clerc,Sarah Cuddy,Vasvi Singh,Marie Foley Kijewski,Giada Bianchi,Andrew J. Yee,Frederick L. Ruberg,Michael Jerosch‐Herold,Raymond Y. Kwong,Marcelo F. Di Carli,Ronglih Liao,Rodney H. Falk,Sharmila Dorbala	2025	0
5	Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy Blood Advances ·Jessica S Little,Angelica Medina Pena,E. Bridget Kim,Andrew J. Yee,Omar Nadeem,Shonali Midha,Adam S. Sperling,Nikhil C. Munshi,Noopur Raje,Matthew J. Frigault,Diana Cirstea,Sarah P. Hammond	2025	1
6	Impact of body mass index on anti-BCMA chimeric antigen receptor T-cell therapy outcomes in multiple myeloma Ruth Choa,Kevin C. Miller,Advait Joshi,Cole Minsky,Samuel Han,Alexis Barselau,Andrew J. Yee,Andrew R. Branagan,Benjamin Puliafito,Matthew J. Frigault,Noopur Raje,Diana Cirstea	2025	0
7	Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial Carolina Digital Repository (University of North Carolina at Chapel Hill) ·Jesús G. Berdeja,Min Yang,Noopur Raje,Edward N. Libby,Simon S. Jones,Nicole Birrer,David Tamang,Peter M. Voorhees,Andrew J. Yee,Robert J Markelewicz,Jeffrey G. Supko,William Bensinger,Jill N. Burke,Ellen Wallace,Paul G. Richardson,Catherine Wheeler	2024	0
8	Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma Blood Cancer Journal ·Rie Nakamoto-Matsubara,Valentina Nardi,Nora Horick,Tsuyoshi Fukushima,Ryan Seongmin Han,Rajib Shome,Kiyosumi Ochi,Cristina Panaroni,Keertik Fulzele,Farah Rexha,Andrew R. Branagan,Diana Cirstea,Andrew J. Yee,David T. Scadden,Noopur Raje	2024	2
9	OA-06 Impact of Clonal Hematopoiesis on Clinical Outcomes to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma Clinical Lymphoma Myeloma & Leukemia ·Joshua Gustine,Andrew R. Branagan,Diana Cirstea,Farah Rexha,Ryan Han,Andrew J. Yee,Matthew J. Frigault,Noopur Raje	2024	1
10	P-008 A Rare and Unexplored Entity of Colitis Post-BCMA Directed CAR T-Cell Therapy; Insights From a Multicenter Case Series Clinical Lymphoma Myeloma & Leukemia ·Noffar Bar,Andrew J. Yee,Binod Dhakal,Matthew J. Frigault,Shambavi Richard,Adam F. Cohen,Sandra P. Susanibar-Adaniya,Adriana Rossi,Dan T. Vogl	2024	1
11	Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis European Heart Journal - Cardiovascular Imaging ·Yesh Datar,Olivier Clerc,Sarah Cuddy,Sirwoo Kim,Alexandra A. Taylor,Jocelyn Canseco Neri,Dominik C. Benz,Giada Bianchi,Andrew J. Yee,Vaishali Sanchorawala,Frederick L. Ruberg,Heather Landau,Ronglih Liao,Marie Foley Kijewski,Michael Jerosch‐Herold,Raymond Y. Kwong,Marcelo F. Di Carli,Rodney H. Falk,Sharmila Dorbala	2024	14
12	A Phase II Study of Isatuximab, Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, in Newly Diagnosed, Transplant-Eligible Multiple Myeloma (The SKylaRk Trial) Blood ·Elizabeth O’Donnell,Clifton C. Mo,Andrew J. Yee,Omar Nadeem,Andrew R. Branagan,Jacob P. Laubach,Jacalyn Rosenblatt,Nora Horick,Paul G. Richardson,Noopur Raje,Diana Cirstea	2023	2
13	Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity Blood ·Charlotte Graham,Won‐Ho Lee,Hadley R. Wiggin,Valentina M. Supper,Mark B. Leick,Filippo Birocchi,Andrew J. Yee,Angelina Petrichenko,J.K. Everett,Frederic D. Bushman,Hossein Sadrzadeh,Otto Rapalino,Daniel Chiu,Isabel Arrillaga‐Romany,Marcela V. Maus,Matthew J. Frigault,Kathleen Gallagher	2023	32
14	Selinexor: Targeting a novel pathway in multiple myeloma SHILAP Revista de lepidopterología ·Clifton C. Mo,Andrew J. Yee,Shonali Midha,Monique Hartley-Brown,Omar Nadeem,Elizabeth O’Donnell,Giada Bianchi,Adam S. Sperling,Jacob P. Laubach,Paul G. Richardson	2023	17
15	Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study Blood Advances ·Gareth P. Gregory,Shaji Kumar,Ding Wang,Daruka Mahadevan,Patricia Walker,Nina D. Wagner‐Johnston,Carolina Escobar,Rajat Bannerji,Divaya Bhutani,Julie Chang,Francisco J. Hernandez‐Ilizaliturri,Andreas K. Klein,John M. Pagel,Witold B. Rybka,Andrew J. Yee,Anne Mohrbacher,Mo Huang,Mohammed Farooqui,Patricia Marinello,Hang Quach	2021	24
16	Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma Nature Cell Biology ·Julia Frede,Praveen Anand,Noori Sotudeh,Ricardo A. Pinto,Monica S. Nair,Hannah T. Stuart,Andrew J. Yee,Tushara Vijaykumar,Johannes M. Waldschmidt,Sayalee Potdar,Jake A. Kloeber,Antonis Kokkalis,Valeriya Dimitrova,Mason L. Mann,Jacob P. Laubach,Paul G. Richardson,Kenneth C. Anderson,Noopur Raje,Birgit Knoechel,Jens G. Lohr	2021	26
17	Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy JACC. Cardiovascular imaging ·Sarah Cuddy,Michael Jerosch‐Herold,Rodney H. Falk,Marie Foley Kijewski,Vasvi Singh,Frederick L. Ruberg,Vaishali Sanchorawala,Heather Landau,Matthew Maurer,Andrew J. Yee,Giada Bianchi,Marcelo F. Di Carli,Ronglih Liao,Raymond Y. Kwong,Sharmila Dorbala	2021	13
18	CT-guided bone marrow aspirations and biopsies: retrospective study and comparison with blind procedures Skeletal Radiology ·Connie Y. Chang,Jad S. Husseini,Agda Marina Ferreira Moreira,F. Joseph Simeone,Andrew J. Yee,Miriam A. Bredella,Robert P. Hasserjian	2020	6
19	Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis JACC. Cardiovascular imaging ·Sarah Cuddy,Paco E. Bravo,Rodney H. Falk,Samir El-Sady,Marie Foley Kijewski,Mi‐Ae Park,Frederick L. Ruberg,Vaishali Sanchorawala,Heather Landau,Andrew J. Yee,Giada Bianchi,Marcelo F. Di Carli,Su-Chun Cheng,Michael Jerosch‐Herold,Raymond Y. Kwong,Ronglih Liao,Sharmila Dorbala	2020	53
20	Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma Molecular Cancer Therapeutics ·Diana Cirstea,Loredana Santo,Teru Hideshima,Homare Eda,Yuko Mishima,Neeharika Nemani,Anuj Mahindra,Andrew J. Yee,Güllü Görgün,Yiguo Hu,Hiroto Ohguchi,Rikio Suzuki,Francesca Cottini,Sylvie M. Guichard,Kenneth C. Anderson,Noopur Raje	2014	24

About Andrew J. Yee

Andrew J. Yee is a scholar working on Hematology, Oncology and Genetics, having authored 127 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (89 papers), Protein Degradation and Inhibitors (36 papers), CAR-T cell therapy research (18 papers), Peptidase Inhibition and Analysis (17 papers), Bone health and treatments (13 papers), Histone Deacetylase Inhibitors Research (11 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). The work is most often cited by research in Hematology (1.0k citations), Oncology (1.1k citations) and Genetics (250 citations). Andrew J. Yee has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Noopur Raje, Elizabeth O’Donnell, Paul G. Richardson, Cristina Panaroni, Homare Eda, Jill N. Burke, Jacob P. Laubach, Simon S. Jones, Matthew J. Frigault and Diana Cirstea. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact